Abcellera Biologics Inc. Aktie
3,68 €
Deine Einschätzung
Abcellera Biologics Inc. Aktie
Was spricht für und gegen Abcellera Biologics Inc. in den nächsten Jahren?
Pro
Kontra
Kommentare
News
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
AbCellera (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) programs at the American Association for Cancer ResearchⓇ (AACR) Annual Meeting 2024 at the San Diego Convention
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
AbCellera (Nasdaq: ABCL) will announce its first quarter 2024 financial results on Tuesday, May 7, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the
AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023
AbCellera (Nasdaq: ABCL) today announced that management will present at the Piper Sandler 35th Annual Healthcare Conference in New York, New York on Thursday, November 30, 2023, at 9:30 a.m